Kronos bio inc.

Other-Pharmaceuticals

KRON


1300 South El Camino Real
San Mateo , CA 94402

Executive/
Director

Price

  • Last Close
  • $ 1
    $ +0.04 3.64 %
    Jan 3, 2025
  • 52-Week High/Low
  • $1.49 - $0.74
  • YTD
  • 4.2%

  • Trading Volume
  • 1,180
  • Market Cap Full
  • $ 58.3M
  • Shares Outstanding
  • 58.3M
    Nov 8, 2023
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 - - - - -5% -0.8% -50.5% -9.9% 4% 4.2%
Q2 - - - - 4% -18% -49.7% 17.8% -13% -
Q3 - - - - 8% -11.7% -8% -24.4% -25.2% -
Q4 - - - - 8.8% -31% -51.6% - -10.6% -
J F M A M J J A S O N D
2025 4.2% - - - - - - - - - - -
2024 -9.6% -8% 25% -23.1% -20.8% 51.5% 9.2% -25.2% - - - -
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    0%0%0%0%0%0%-50%-89%-23%-23%4%

Earnings

2018 2019 2021 2022 2023
Q1 - - -0.48 -0.65 -0.46
Q2 - - -0.53 -0.59 -0.52
Q3 - - -0.61 -0.57 -0.54
Q4 - - -1.14 -0.56 -
A 0 0 -2.8 -2.4 -1.52

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2020 2021 2022 2023
Mar - 56 56.6 57.6
Jun - 56.1 56.7 57.6
Sep - 56.3 56.8 58.3
Dec 56 56.3 56.9 58.3

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - - - - -
Total Asset Turnover - - - - -
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage 34.3 - -1.9 17 -
Equity multiplier 0.1 0.1 0.1 0.1 -